Skip to main content
Veterinary Medicines

Paracox-8 vet suspensio oraalisuspensiota varten kanoille

Authorised
  • Eimeria tenella, strain HP, Live
  • Eimeria praecox, strain HP, Live
  • Eimeria necatrix, strain HP, Live
  • Eimeria mitis, strain HP, Live
  • Eimeria maxima, strain MFP, Live
  • Eimeria maxima, strain CP, Live
  • Eimeria brunetti, strain HP, Live
  • Eimeria acervulina, strain HP, Live

Product identification

Medicine name:
Paracox-8 vet suspensio oraalisuspensiota varten kanoille
Active substance:
  • Eimeria tenella, strain HP, Live
  • Eimeria praecox, strain HP, Live
  • Eimeria necatrix, strain HP, Live
  • Eimeria mitis, strain HP, Live
  • Eimeria maxima, strain MFP, Live
  • Eimeria maxima, strain CP, Live
  • Eimeria brunetti, strain HP, Live
  • Eimeria acervulina, strain HP, Live
Target species:
  • Chicken
Route of administration:
  • Nebulisation use
  • In drinking water use

Product details

Active substance and strength:
  • Eimeria tenella, strain HP, Live
    500.00
    oocyst(s)
    /
    1.00
    Dose
  • Eimeria praecox, strain HP, Live
    100.00
    oocyst(s)
    /
    1.00
    Dose
  • Eimeria necatrix, strain HP, Live
    500.00
    oocyst(s)
    /
    1.00
    Dose
  • Eimeria mitis, strain HP, Live
    1000.00
    oocyst(s)
    /
    1.00
    Dose
  • Eimeria maxima, strain MFP, Live
    100.00
    oocyst(s)
    /
    1.00
    Dose
  • Eimeria maxima, strain CP, Live
    200.00
    oocyst(s)
    /
    1.00
    Dose
  • Eimeria brunetti, strain HP, Live
    100.00
    oocyst(s)
    /
    1.00
    Dose
  • Eimeria acervulina, strain HP, Live
    500.00
    oocyst(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for oral suspension
Withdrawal period by route of administration:
  • Nebulisation use
    • Chicken
      • Not applicable
        0
        day
  • In drinking water use
    • Chicken
      • Not applicable
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AN01
Authorisation status:
  • Valid
Authorised in:
  • Finland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Merck Sharp & Dohme Animal Health S.L.
  • MSD Animal Health UK Limited
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 13530
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 26/01/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 26/01/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."